Konstantinos Vlachtsis

Konstantinos Vlachtsis

Auto-generated profile, based on publicly available information

Konstantinos Vlachtsis

Department of Otorhinolaryngology‐Head and Neck Surgery "G. Papanikolaou" General Hospital Thessaloniki Greece

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2021 in Indian Journal of Otolaryngology and Head & Neck Surgery
Verified
Journal Article
Closed access
PDF file
KVKonstantinos Vlachtsis
Konstantinos Vlachtsis
NTNikolaos Tsetsos
Nikolaos Tsetsos
SSSotiria Sotiroudi
Sotiria Sotiroudi
MSMarios Stavrakas
Marios Stavrakas
GFGeorgios Fyrmpas
Georgios Fyrmpas
ANAngelos Nikolaou
Angelos Nikolaou

8 March 2021 in Cancers
Verified
Journal Article
Open access
PDF file
FDFoteinos-Ioannis Dimitrakopoulos
Foteinos-Ioannis Dimitrakopoulos
GKGeorgia-Angeliki Koliou
Georgia-Angeliki Koliou
VKVassiliki Kotoula
Vassiliki Kotoula
KPKyriaki Papadopoulou
Kyriaki Papadopoulou
KMKonstantinos Markou
Konstantinos Markou
AKAngelos Koutras
Angelos Koutras
Head and neck cancer (HNC) is a significantly heterogeneous disease and includes malignancies arising from different anatomical sites, such as nasopharyngeal cancer (NPC) and laryngeal cancer (LC). In the current study, polymorphisms located in angiogenesis- and apoptosis-related genes (VEGFA, FAS, EDNRA and NBS1) were evaluated regarding their clinical significance in HNC patients. In total, 333 HNC patients were enrolled in this study and 34 variants located on the aforementioned genes were genotyped via Sanger sequencing. LC patients, homozygous A for VEGFA rs13207351, had shorter overall survival (OS) as opposed to homozygous G (Hazard ratio (HR) = 2.06, Wald’s p = 0.017) upon adjustment for age, disease stage, and surgery. Following the dominant model, LC patients carrying the A allele had a marginally significantly higher risk for death (HR = 1.72, p = 0.059). NPC patients heterozygous (CT) for FAS rs2234768 had a marginal but significantly higher risk of death compared to those with homozygosity for the T allele (HR = 2.22, p = 0.056). In conclusion, rs13207351 (VEGFA) and rs2234768 (FAS) polymorphisms seem to have prognostic significance in HNC, with VEGFA rs13207351 showing the most promise in this subgroup of LC patients.

20 December 2021 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
GFGeorgios Fyrmpas
Georgios Fyrmpas
NTNikolaos Tsetsos
Nikolaos Tsetsos
APAlexandros Poutoglidis
Alexandros Poutoglidis
AAAhmad Alghoj
Ahmad Alghoj
KVKonstantinos Vlachtsis
Konstantinos Vlachtsis

2 September 2021 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
AKAdamantios Kilmpasanis
Adamantios Kilmpasanis
NTNikolaos Tsetsos
Nikolaos Tsetsos
APAlexandros Poutoglidis
Alexandros Poutoglidis
ATAikaterini Tsentemeidou
Aikaterini Tsentemeidou
SSSotiria Sotiroudi
Sotiria Sotiroudi
KVKonstantinos Vlachtsis
Konstantinos Vlachtsis
Significance Statement: Facial nerve schwannoma is extremely uncommon. Despite its rarity, it is considered the most common facial nerve tumor and potentially affects any segment of the nerve. Presenting symptoms vary depending on the location of the neoplasm. Tumors pertaining to the extratemporal course of the nerve mainly appear as an asymptomatic parotid mass. We present a rare case of schwannoma of the zygomatic branch of the right facial nerve that was surgically resected, without facial nerve injury.